Henning D. Mootz
- Pharmacology top 0.1%
- Microbial Natural Products and Biosynthesis 27
- Biotechnology top 0.5%
- Molecular Biology top 1%
- RNA and protein synthesis mechanisms 54
- Chemical Synthesis and Analysis 46
- Biochemical and Structural Characterization 31
- Ubiquitin and proteasome pathways 18
- Microbiology top 1%
- Organic Chemistry top 2%
- Click Chemistry and Applications 26
-
- Monoclonal and Polyclonal Antibodies Research 32
-
- Peptidase Inhibition and Analysis 20
- Co-authors
- Mohamed A. MarahielTorsten StachelhausDirk SchwarzerTom W. MuirUwe LinneJ. L. ZettlerGerrit VolkmannVeit Bergendahl
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
Henning D. Mootz
128 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Pharmacology 2.8k
- Biotechnology 743
- Molecular Biology 5.7k
- Microbiology 434
- Organic Chemistry 1.1k
Countries citing papers authored by Henning D. Mootz
This map shows the geographic impact of Henning D. Mootz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning D. Mootz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning D. Mootz more than expected).
Fields of papers citing papers by Henning D. Mootz
This network shows the impact of papers produced by Henning D. Mootz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning D. Mootz. The network helps show where Henning D. Mootz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Henning D. Mootz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2022 | 12 | |
| 8 | 2021 | 16 | |
| 9 | 2021 | 1 | |
| 10 | 2021 | 25 | |
| 11 | 2019 | 34 | |
| 12 | 2018 | 28 | |
| 13 | 2015 | 26 | |
| 14 | 2014 | 8 | |
| 15 | 2013 | 5 | |
| 16 | 2011 | 25 | |
| 17 | 2010 | 13 | |
| 18 | 2009 | 19 | |
| 19 | 2002 | 173 | |
| 20 | 2001 | 42 |
About Henning D. Mootz
Henning D. Mootz is a scholar working on Molecular Biology, Microbiology and Pharmacology, having authored 133 papers that have together received 6.9k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (54 papers), Chemical Synthesis and Analysis (46 papers), Monoclonal and Polyclonal Antibodies Research (32 papers), Biochemical and Structural Characterization (31 papers), Microbial Natural Products and Biosynthesis (27 papers), Click Chemistry and Applications (26 papers), Peptidase Inhibition and Analysis (20 papers) and Ubiquitin and proteasome pathways (18 papers). The work is most often cited by research in Pharmacology (2.8k citations), Biotechnology (743 citations) and Molecular Biology (5.7k citations). Henning D. Mootz has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include Mohamed A. Marahiel, Torsten Stachelhaus, Dirk Schwarzer, Tom W. Muir, Uwe Linne, J. L. Zettler, Gerrit Volkmann, Veit Bergendahl, Stefanie Sommer and Christina Ludwig. Their work appears in journals such as Nature, Science and Chemical Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.